-
Posted by
Two Blokes May 2 -
Filed in
Stock
-
4 views
Alexandria Real Estate Equities' 7.3% dividend yield appears well-covered, but is threatened by declining occupancy and political uncertainties impacting biotech funding and drug approvals. Despite beating Q1 2025 earnings expectations, ARE lowered its FY 2025 AFFO guidance, with falling occupancy and rising expenses posing significant risks to dividend safety. The biopharma sector's bear market and high layoffs are reducing lease opportunities for ARE, though long-term leases and investment-grade tenants offer some stability.
